Key result
Concurrent atrial fibrillation significantly increased the risk of in-hospital mortality in patients with stroke or TIA compared to those without AF (15.78% vs 7.01%; OR 2.485, 95% CI 2.023-3.053).
Why the study?
Does atrial fibrillation increase in-hospital mortality in patients with stroke or TIA?
Observational (n=7,921)
Does atrial fibrillation increase in-hospital mortality in patients with stroke or TIA?
Odds Ratio: 2.485 (95% CI 2.023–3.053)
Absolute Event Rate: 15.78% vs 7.01%
p-value: p=<0.001
Atrial fibrillation significantly increases in-hospital mortality in patients with stroke or TIA, yet preventive anticoagulant therapy remains severely underutilized.
AF screening in stroke/TIA may improve detection; leaves open optimal strategies and duration.
Background. Stroke takes the second place among all causes for cardiovascular death and the first place in mortality and disability among other nervous system diseases. Atrial fibrillation (AF) is presently is a commonly recognized, independent risk factor for ischemic stroke, which fivefold increases the risk of an unfavorable outcome. Prevention of stroke is a complicated medical and social challenge. Aim. To study AF prevalence among patients with stroke/ transient ischemic attack (TIA) who had received an anticoagulant therapy before hospitalization. Materials and methods. A retrospective analysis of case reports was performed for patients diagnosed with acute cerebrovascular disease and TIA who had received a therapy from January, 2013 through December, 2015 (n=7921). From these case reports, 849 case reports of patients with concurrent AF were selected. Results. In patients with stroke/TIA, the AF incidence was 10.72%. Risk assessment using the CHA 2 DS 2 -VASc scale showed that the percentage of low-risk patients (score 0) was 0.8%, intermediate risk patients (score 1) - 5.3%, and high-risk patients (score ≥2) - 93.8%; 4.7% of patients with AF received preven tive therapy for thromboembolic complications. The death rate of patients with AF and stroke/TIA was 15.78% whereas in-hospital death rate of patients without AF was 7.01%. Therefore, AF is a statistically significant risk factor of in-hospital mortality for patients with stroke/TIA (OR=2.485, 95% CI: 2.023-3.053, p<0.001,). The following factors influenced the in-hospital mortality of patients with ischemic stroke and concurrent AF: severe CHF, type 2 diabetes mellitus, peripheral thrombosis, history of a transcutaneous coronary intervention, oncological disease, and impaired glomerular filtration rate. Conclusion. The study demonstrated an effect of AF on in-hospital mortality of patients with ischemic stroke and a low rate of preventive anticoagulant therapy in patients with AF.
No takes yet. Share an insight, caveat, or question.
Акпанова et al. (2018) conducted an observational in Stroke and transient ischemic attack (TIA) (n=7,921). Atrial fibrillation vs. No atrial fibrillation was evaluated on In-hospital mortality (OR 2.485, 95% CI 2.023-3.053, p=<0.001). Concurrent atrial fibrillation significantly increased the risk of in-hospital mortality in patients with stroke or TIA compared to those without AF (15.78% vs 7.01%; OR 2.485, 95% CI 2.023-3.053).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: